Skip to main content
Premium Trial:

Request an Annual Quote

Personalis Establishes UK Subsidiary

NEW YORK (GenomeWeb News) – Personalis has formed a UK subsidiary, Personalis UK Limited, to serve its customers in Europe.

Menlo Park, Calif.-based Personalis provides researchers and clinicians human DNA sequencing and interpretation services.

The company also announced that it has appointed Mark Dronsfield to the post of director of European sales. He joins the company from RainDance Technologies, where he served as head of commercial operations in Europe, and has previously held commercial operations positions in Europe for Illumina, Affymetrix, and Life Technologies.

Personalis plans to initially build out its commercial team in the UK, but will also build services infrastructure as the customers' needs require.

"Given the expanding research and clinical demands for large-scale exome and genome analysis, we felt it was important to augment our presence in the European markets," said Personalis CEO John West in a statement. "We wanted to be prepared to build infrastructure on both the commercial and operational sides, so we are best able to address the needs of researchers and clinicians."

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.